ATE459248T1 - Tiermodell zur berechnung von impstoffen - Google Patents

Tiermodell zur berechnung von impstoffen

Info

Publication number
ATE459248T1
ATE459248T1 AT98914591T AT98914591T ATE459248T1 AT E459248 T1 ATE459248 T1 AT E459248T1 AT 98914591 T AT98914591 T AT 98914591T AT 98914591 T AT98914591 T AT 98914591T AT E459248 T1 ATE459248 T1 AT E459248T1
Authority
AT
Austria
Prior art keywords
vaccines
hiv
animal model
human
evaluating
Prior art date
Application number
AT98914591T
Other languages
English (en)
Inventor
Lung-Ji Chang
Original Assignee
Amdl Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/848,760 external-priority patent/US6248721B1/en
Application filed by Amdl Inc filed Critical Amdl Inc
Priority claimed from PCT/US1998/006944 external-priority patent/WO1998044788A2/en
Application granted granted Critical
Publication of ATE459248T1 publication Critical patent/ATE459248T1/de

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT98914591T 1997-04-09 1998-04-09 Tiermodell zur berechnung von impstoffen ATE459248T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US83870297A 1997-04-09 1997-04-09
US08/848,760 US6248721B1 (en) 1997-04-09 1997-05-01 Method of using mouse model for evaluation of HIV vaccines
US6916397P 1997-12-09 1997-12-09
PCT/US1998/006944 WO1998044788A2 (en) 1997-04-09 1998-04-09 Animal model for evaluation of vaccines

Publications (1)

Publication Number Publication Date
ATE459248T1 true ATE459248T1 (de) 2010-03-15

Family

ID=39909295

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98914591T ATE459248T1 (de) 1997-04-09 1998-04-09 Tiermodell zur berechnung von impstoffen

Country Status (4)

Country Link
JP (1) JP2008237216A (de)
AT (1) ATE459248T1 (de)
DE (1) DE69841529D1 (de)
IL (1) IL132164A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019147869A2 (en) * 2018-01-24 2019-08-01 Virogin Biotech Canada Ltd Recombinant viral vaccines

Also Published As

Publication number Publication date
IL132164A (en) 2007-03-08
DE69841529D1 (de) 2010-04-15
JP2008237216A (ja) 2008-10-09

Similar Documents

Publication Publication Date Title
ATE326479T1 (de) Varianten von antigenen des menschlichen papillomvirus
SG46445A1 (en) Vaccines against cancer and infectious diseases
NO20001768L (no) Viruskapsomervaksine, fremgangsmÕte til fremstilling samt anvendelse derav
ATE280496T1 (de) Verfahren zur behandlung von asthma mit o- desulfatisiertem heparin
DE69800716D1 (de) Neues verfahren zur herstellung von anti-humanen antigenrezeptoren und deren verwendungen
CO5070644A1 (es) Vacunas que comprenden proteinas e6 de hpv y/o e7 de hpv junto con un oligonucleotido cpg como adyudante
NL930133I2 (nl) Vaccin tegen hepatitis B virus, werkwijze en getransformeerde eukaryotische cellen en de bereiding van dat vaccin.
DK0561890T3 (da) DNA ekspressionssystemer baseret på alphavira
DE69637642D1 (de) Und kombinierte zusammensetzungen und deren verwendung
DK0584348T3 (da) Genetisk vaccine mod immundefektvirusser
ZA837603B (en) Immunogenic protein or peptide complex,method of producing said complex and the use thereof as an immune stimulant and as a vaccine
DE60043708D1 (de) Verfahren zur erhaltung zellimmuneantworten gegen proteinen
ATE187775T1 (de) Verfahren zur herstellung von menschlichem serumalbumin in hefe
ATE306939T1 (de) Mehrstufiger kaskade-erhöhungsimpfstoff
ZA862812B (en) Antigens related to envelope glycoprotein of the virus of aids,methods of obtaining these antigens and means employed in these methods
BG102809A (en) Vaccine against the reproductive and respiratory syndrome in pigs
WO1998044788A3 (en) Animal model for evaluation of vaccines
FI811685A7 (fi) Menetelmä virusperäisten glykoproteiiniantigeenien eristämiseksi ja niiden käyttö rokotteiden vvalmistukseen.
DE69841529D1 (de) Tiermodell zur Berechnung von Impstoffen
FI875015A0 (fi) Vaccin mot juverinflammation.
DE3889581D1 (de) Monoklonale Antikörper gegen spezifische antigene Regionen des humanen Immundefizienzvirus und Methoden zur Verwendung.
TW200504216A (en) Immunization of fish with plant-expressed recombinant proteins
ATE58836T1 (de) Verfahren zur gewinnung haltbarer wirkstoffreicher kamillenextrakte.
WO2003066833A3 (en) Use of recombinant hepatitis b core particles to develop vaccines against infectious pathogens and malignancies
DK76191A (da) Filamentoest haemagglutinin fra b.pertussis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties